img-1
Society News

ICIS Elections: Last Day to Vote is July 31, 2024

Each year Members of ICIS are asked to elect members of the governing council and nominations committee. This year, members are also asked to vote on a change to the Bylaws of the Society regarding Standing Committees. These important elections determine the direction and the future of the Society.    All [READ MORE]

Banner Image of ICIS President, Sarah Gaffen
Featured Article!

Democracy in Action: ICIS Leadership Elections and Other Voting Opportunities

“Vote early, vote often” is a humorous quip often attributed to the organized crime era of Chicago in the early 1900s. At the Cytokine Society we do not sanction multiple voting – but all members in good standing are encouraged to cast your ballot legitimately in the upcoming elections for [READ MORE]

No Picture
Society News

Leadership and Governance Elections

Voting for ICIS Leadership and a change to the Bylaws is open from July 1 – 31, 2024. All ICIS Members in good standing are eligible and encouraged to vote and exercise your right to determine the future of the International Cytokine and Interferon Society. Council and Nominations Committee Election [READ MORE]

The ICIS office has moved from Oradell, NJ to San Francisco, CA.
Society News

We’ve Moved!

The ICIS continues to be managed as a virtual office, now with one office in San Francisco and one in Germany. Since the society is a US registered non-profit organization that has been incorporated in the US, and Co-Managing Director, Stephanie Flores is located in San Francisco, please use the [READ MORE]

Graphic Image of Hands in a Circle
Society News

Invite a colleague to join the ICIS Family!

Each year, the International Cytokine & Interferon Society (ICIS) is thrilled to welcome approximately 200 new members, each bringing unique experiences and perspectives that enrich our community. Did you know that you can meet many of these new members in our regular Signals+ feature, New Member Mini-Bios? Reach out, welcome [READ MORE]

We've Moved
Society News

We’ve Moved!

The ICIS continues to be managed as a virtual office, now with one office in San Francisco and one in Germany. Since the society is a US registered non-profit organization that has been incorporated in the US, and Co-Managing Director, Stephanie Flores is located in San Francisco, please use the [READ MORE]

We've Moved
Society News

We’ve Moved!

The ICIS continues to be managed as a virtual office, now with one office in San Francisco and one in Germany. Since the society is a US registered non-profit organization that has been incorporated in the US, and Co-Managing Director, Stephanie Flores is located in San Francisco, please use the [READ MORE]

Graphic Image of Signals+
Society News

Reflecting on Six Months of the New Signals+: Your Feedback & Contributions Matter

Dear ICIS Members, Cytokine & Interferon Researchers & Industry Partners, It’s hard to believe that six months have flown by since we introduced the new, semi-monthly Signals+ in partnership with Multiview. Time truly does fly when you’re staying informed and engaged in the dynamic world of cytokine and interferon research. [READ MORE]

Last Call for Nominations for ICIS Leadership Positions
Society News

Last Call for Nominations for ICIS Leadership Positions

Submit Nomination Today Deadline to Submit Nomination or Self-Nominate: April 5, 2024 The International Cytokines & Interferon Society (ICIS) is on the lookout for outstanding individuals to fill six pivotal leadership roles. This is your chance to steer the course of our society and make a significant impact. If you [READ MORE]

Graphic - Call for Nominations
Society News

ICIS Leadership: Nominate Someone Today!

The International Cytokines & Interferon Society (ICIS) thrives on the invaluable contributions of individuals who generously devote their time and expertise to the Society. As we look to the future, we invite you, our members, to consider stepping into leadership roles that will drive the field of cytokine and interferon research to new heights. [READ MORE]